Search

So what exactly are you looking for? Let us know and we will help you find the best answer

Clear All

Lyka Labs Ltd.

  • NSE: LYKALABS

  • BSE: 500259

  • Q
  • V
  • T
  • Momentum Trap
28.45/100

Quality Score

Low Financial Strength
28.50/100

Valuation Score

Expensive Valuation
53.20/100

Technical Score

Technically Neutral
Broker Average Rating

0.00

Broker Average Rating

MFI

31.22

MFI is mid-range

50Day SMA Rs

19.46 Rs

price crossed below SMA50 today

Quality score

28.45

Low Financial Strength

30Day SMA Rs

20.12 Rs

Price below SMA-30

Broker Covering stock

0.00

None Broker Covering stock

Broker 6M Target upgrade

0.00

None Broker 6M Target upgrade

Broker 6M Target downgrade

0.00

None Broker 6M Target downgrade

Momentum score

53.20

Technically Neutral

Price to Book Ratio

1.17

Below industry Median

Broker Reports in 1Yr

0.00

None Broker Reports in 1Yr

TTM PE Ratio

-0.87

Negative PE Trailing 12M

Broker 6M Reco upgrade

0.00

None Broker 6M Reco upgrade

RSI

46.53

RSI is mid-range

Net Profit Qtr Cr

-4.09 Cr

Negative Net Profit Qtr Cr

Operating Revenues Qtr Cr

17.72 Cr

Below industry Median

MACD

-0.18

MACD below Signal and Center

Valuation score

28.50

Expensive Valuation

MACD Signal Line

-0.13

MACD below Signal and Center

FII holding holding %

3.50 %

No change in FII holding

Promoter holding holding %

19.88 %

No change in Promoter holding

MF holding holding %

0.01 %

No change in MF holding

Broker 6M Reco downgrade

0.00

None Broker 6M Reco downgrade

100Day SMA Rs

18.65 Rs

Price above SMA 18.65

Institutions holding holding %

4.15 %

Institutions holding decreased by 0.01%.

200Day SMA Rs

18.26 Rs

Price above SMA 18.26

NSE LYKALABS
19.20
  • 19.30 Close
  • 19.75 Open
  • 22.43 K Volume
Today Low/High
Low 18.95
High 19.80
52 Week Low/High
23-03-2020 9.60
26-06-2020 24.70

Peer Comparison

All values except ratios in INR(Crores)

Stock Name Current Price Rs PE TTM Price To Earnings Market Capitalization In Cr Dividend Yield 1yr % Net Profit Qtr Cr Net Profit Annual Growth YoY % Operating Revenues Qtr Cr Revenue Growth Qtr YoY Price To Book Value
Lyka Labs Ltd. 19.1 -0.88 54.79 0 -4.09 0 17.71 23.35 1.17
Sun Pharmaceutical Industries Ltd. 523.35 491.26 125567.36 0.76 -2429.81 0 7585.25 -9.43 2.55
Divi's Laboratories Ltd. 3344.4 55.61 88777.09 0.47 492.06 0 1730.47 48.8 12.14
Dr. Reddy's Laboratories Ltd. 5333.35 46.73 88640.27 0.46 586.9 0 4426.5 14.72 5.68
Cipla Ltd. 806.25 39.44 65003.9 0.49 571.42 0 4346.16 8.95 4.04
Lupin Ltd. 1085.9 -105.29 49202.12 0.55 108.14 0 3527.86 -20.16 3.91
Torrent Pharmaceuticals Ltd. 2876.3 43.07 48678.5 1.11 321 0 2056 1.68 10.09
Aurobindo Pharma Ltd. 828.1 16.13 48518.37 0.51 792.68 0 5924.78 8.81 2.88